Phyllodes tumor of the prostate.

Rare and challenging tumor entity: phyllodes tumor of the prostate. J Oncol (2009) 1.08

A large cystic phyllodes tumor of the prostate. Yonsei Med J (2009) 0.93

Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer (2004) 1.85

Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol (2008) 1.64

Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin Cancer Res (2005) 1.63

Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol (2009) 1.63

Evidence for common clonal origin of multifocal lung cancers. J Natl Cancer Inst (2009) 1.59

ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol (2011) 1.59

Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia (2004) 1.56

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status. Cancer (2004) 1.45

Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res (2004) 1.45

Leiomyoma of the urethra and bladder. J Urol (2007) 1.44

Intestinal metaplasia of the bladder. J Urol (2006) 1.41

Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation. J Urol (2002) 1.40

Prostatic stromal hyperplasia with atypia: follow-up study of 18 cases. Arch Pathol Lab Med (2008) 1.33

Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol (2010) 1.33

Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res (2007) 1.32

Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol (2009) 1.24

Inflammatory myofibroblastic tumors of the genitourinary tract--single entity or continuum? J Urol (2008) 1.22

Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol (2005) 1.21

Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol (2010) 1.19

Ureteral endometriosis: clinicopathological and immunohistochemical study of 7 cases. Hum Pathol (2008) 1.19

Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res (2005) 1.19

Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol (2005) 1.19

Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J Clin Oncol (2003) 1.15

Large cell calcifying Sertoli cell tumor of testis. J Urol (2007) 1.13

Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors. Hum Pathol (2007) 1.13

Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol (2011) 1.11

Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin Cancer Res (2007) 1.09

Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin Cancer Res (2007) 1.08

Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Clin Cancer Res (2008) 1.08

Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer (2003) 1.07

Soft tissue tumors of the urinary bladder Part II: malignant neoplasms. Hum Pathol (2007) 1.07

Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization. Hum Pathol (2008) 1.05

Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol (2006) 1.05

TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol (2008) 1.05

Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol (2007) 1.05

Molecular imaging of NF-kappaB in prostate tissue after systemic administration of IL-1 beta. Prostate (2008) 1.04

Xanthogranulomatous sialadenitis: a case report and literature review. Ear Nose Throat J (2005) 1.01

Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice. FASEB J (2005) 1.00

Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression. PLoS One (2013) 0.99

Primary testicular lymphoma. J Urol (2007) 0.99

Radiation cystitis. J Urol (2009) 0.98

Small cell carcinoma of the urinary bladder. Histol Histopathol (2010) 0.97

Laser-assisted microdissection in translational research: theory, technical considerations, and future applications. Appl Immunohistochem Mol Morphol (2013) 0.97

Adenomatoid tumor of the adrenal gland. J Urol (2008) 0.97

Prostatic leiomyoma with atypia: follow-up study of 10 cases. Ann Diagn Pathol (2008) 0.97

Squamous cell carcinoma of the renal pelvis. J Urol (2010) 0.96

Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma. Clin Cancer Res (2008) 0.95

Carcinoid tumor of the kidney. J Urol (2008) 0.94

Sarcomatoid urothelial carcinoma of the renal pelvis. J Urol (2006) 0.94

Endometriosis of the ureter. J Urol (2008) 0.94

Mucinous tubular and spindle cell carcinoma of the kidney. J Urol (2009) 0.94

Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis. Prostate (2008) 0.93

Il-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation. Prostate (2009) 0.93

Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model. Pharm Res (2011) 0.92

c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol (2005) 0.92

Soft tissue tumors of the penis: a review. Anal Quant Cytol Histol (2006) 0.92

Benign soft tissue tumors of the testis. J Urol (2009) 0.91

Small cell carcinoma of the urinary bladder--histogenesis, genetics, diagnosis, biomarkers, treatment, and prognosis. Appl Immunohistochem Mol Morphol (2007) 0.91

Sarcoidosis of the testis and epididymis. J Urol (2008) 0.91

FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations. Mod Pathol (2009) 0.91

Ganglioneuroma of the adrenal gland. J Urol (2009) 0.90

The landscape of EGFR pathways and personalized management of non-small-cell lung cancer. Future Oncol (2011) 0.90

The clinical and therapeutic implications of cancer stem cell biology. Expert Rev Anticancer Ther (2011) 0.89

Ectopic prostatic tissue: histogenesis and histopathological characteristics. Histopathology (2011) 0.89

Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor. Cancer (2002) 0.89

Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults. Urol Oncol (2010) 0.89

Interphase fluorescence in situ hybridization analysis of chromosome 12p abnormalities is useful for distinguishing epidermoid cysts of the testis from pure mature teratoma. Clin Cancer Res (2006) 0.87

Renal medullary carcinoma. J Urol (2005) 0.87

Renal epithelioid angiomyolipoma. J Urol (2009) 0.86

Failure to detect the presence of prions in the uterine and gestational tissues from a Gravida with Creutzfeldt-Jakob disease. Am J Pathol (2009) 0.85

The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. Ann Diagn Pathol (2002) 0.85

Histologic grading of urothelial carcinoma: a reappraisal. Hum Pathol (2012) 0.85

Primary melanoma of the bladder. J Urol (2011) 0.85

Cyclin E as molecular marker in the management of breast cancer: a review. Anal Quant Cytol Histol (2006) 0.85

Quantitative evaluation of 2-deoxy-2[F-18]fluoro-D-glucose-positron emission tomography imaging on the woodchuck model of hepatocellular carcinoma with histological correlation. Mol Imaging Biol (2007) 0.84

Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer (2004) 0.84

Retroperitoneal liposarcoma. J Urol (2007) 0.84

Allelic loss of the active X chromosome during bladder carcinogenesis. Arch Pathol Lab Med (2004) 0.84

Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art. Crit Rev Oncol Hematol (2010) 0.84

Renal cell carcinoma and other concurrent renal neoplasms. J Urol (2007) 0.83

Evidence for clonal fibroblast proliferation and autoimmune process in idiopathic retroperitoneal fibrosis. Hum Pathol (2012) 0.83

Benign vascular lesions of the scrotum. J Urol (2006) 0.83

Extramammary Paget's disease of the penis and scrotum. J Urol (2009) 0.83

Human papillomavirus is not an etiologic agent of urothelial inverted papillomas. Am J Surg Pathol (2013) 0.83

Renal cell carcinoma metastasis to the bladder. J Urol (2010) 0.82

Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Prostate (2011) 0.82

Juxtaglomerular cell tumor of the kidney. J Urol (2006) 0.82

Follicular large cell lymphoma localized to the testis in children. J Urol (2002) 0.82

Epidermoid cyst of the testis. J Urol (2008) 0.81

Small cell carcinoma of the prostate. J Urol (2008) 0.81

KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas. Histopathology (2012) 0.81

Testicular vasculitis. J Urol (2006) 0.81

Unusual female suburethral mass lesions. J Urol (2005) 0.81

Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer. Anal Quant Cytol Histol (2009) 0.81

Clear cell sarcoma of the kidney. J Urol (2011) 0.80

Molecular determinants of tumor recurrence in the urinary bladder. Future Oncol (2009) 0.80

Retroperitoneal seminoma in limited biopsies: morphologic criteria and immunohistochemical findings in 30 cases. Am J Surg Pathol (2006) 0.79

Evidence for transformation of fibroadenoma of the breast to malignant phyllodes tumor. Appl Immunohistochem Mol Morphol (2009) 0.79

Paraganglioma of the prostate. J Urol (2006) 0.79

Screening for intratubular germ cell neoplasia of the testis using OCT4 immunohistochemistry. Am J Surg Pathol (2006) 0.78